Danger score versus ER volume
Danger score versus ER volume
According to CPSC NEISS 2005-2024, Antihistamines ranks #370 of 838 by danger score (36/100) at ER-volume #294 of 838 (4,808/yr). They are not the same ranking.
- #370
- danger rank of 838
- #294
- ER-volume rank of 838
- 36/100
- danger score
- 4,808/yr
- estimated ER visits (avg)
Danger score combines injury volume, hospitalization, fatality, and five-year trend. ER volume is the average annual NEISS estimate alone. Rank 1 is highest on each list.
Where this category's danger score sits nationally
Danger score (36/100) across 838 scored CPSC product categories
36 Around the middle lower than 44% of 838 product categories
scored CPSC product categories, bucketed by value
Each bar is a band; taller bars hold more product categories. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source CPSC NEISS, PlainSafety danger-score model · 2024
Composite verdict
Composite Safety Score: 46/100
One verdict blending 4 independently-sourced dimensions from two separate CPSC systems, each benchmarked against all 838 scored product categories by percentile rather than raw value, so no single huge-volume category can dominate the scale.
| Dimension | Value | National percentile | Weight applied | Source |
|---|---|---|---|---|
| Injury severity (hospitalization + fatality blend) | 7 | 59th | 35% | CPSC NEISS 20-year severity index |
| Annual ER injury volume | 4,808 | 58th | 30% | CPSC NEISS estimated annual ER-treated injuries |
| 5-year injury trend | -23% | 30th | 15% | CPSC NEISS 5-year % change in ER-treated injuries |
| Consumer incident reports | 1 | 18th | 20% | CPSC SaferProducts.gov public incident report count |
Methodology: each dimension is ranked against the full population's p10/p25/p50/p75/p90 breakpoints and interpolated to a 0-100 percentile; the composite is the weighted average of available percentiles. See methodology for the full benchmark table.
Where 96,155 estimated ER injuries land on the body
Body-part shares from the same CPSC NEISS injury_types extract for product code 1928. Segments sum to 96,155 - a body-map mix, not a danger score or ER-volume rank.
Two danger lenses
Same-group peer scores and this product's dial
The bars compare PlainSafety danger scores inside the Transportation & Substances group (same CPSC NEISS extract). The dial is this product's score alone on the Low/Moderate/High bands. Do not read a peer bar as an ER-visit count.
Transportation & Substances danger scores
How this 36/100 score is built
The score is computed from four CPSC-derived factors for antihistamines - no opinion, no editorializing:
- Injury volume 4,808 ER visits/yr Above median volume
- Severity (hospitalization rate) 7.1% Above median admission rate
- Fatality rate 0.00% No recorded fatalities
- 5-year trend-23%
Band labels compare this category against the corpus of 838 scored CPSC product categories, see the full methodology for the exact weighting of each factor.
What the CPSC Data Shows
Across the 20-year NEISS window from 2005 to 2024, injury counts for antihistamines are declining by about 23% over the last five years, with the busiest year on record being 2014 (6,206 estimated ER visits) and the quietest 2022 (3,220 estimated visits). The single most common ER diagnosis is poisoning to the all parts body, accounting for approximately 96,106 visits across the 20-year NEISS window, followed by contusions, abr. to the face (28 cases). The 0-4 age group absorbs the largest share of injuries, about 96,160 cases over the NEISS window, and males appear slightly more often than the opposite sex in that cohort. Severity outcomes from the NEISS disposition field show that 7.1% of ER visits involving this product end in hospital admission or transfer.
Beyond the hospital-sampled NEISS projections, this page also aggregates 1 consumer incident report filed directly on SaferProducts.gov, plus 20 anonymized ER narratives - together forming a layered picture of how antihistamines fail in real households. Every figure on this page comes from CPSC-published data: NEISS projects national estimates from a probability sample of about 100 U.S. hospital emergency departments, while SaferProducts.gov collects voluntary reports from consumers, manufacturers, and clinicians. The danger score, trend indicators, and demographic breakdowns update automatically when CPSC releases a new yearly NEISS file, which is why this page is dated 2024-12-31. For regulatory context, consult CPSC recall notices and the SaferProducts.gov public database linked below.
Annual Injury Estimates (2005–2024)
Source: CPSC NEISS national estimates Injuries represent ER-treated cases only
Who Gets Injured?
| Age Group | Male | Female | Total |
|---|---|---|---|
| 0-4 | 50,731 | 45,429 |
Most Common Injuries
| Body Part | Diagnosis | Est. Injuries |
|---|---|---|
| All Parts Body | Poisoning | |
| Face | Contusions, Abr. | |
| Mouth | Laceration | |
| Eyeball | Derma/conjunct | |
| Face | Foreign Body | |
| Internal | Aspiration |
Severity Breakdown
ER Visit Narratives
Real anonymized emergency room reports from the CPSC NEISS database.
4YOF POSSIBLE INGESTION ON 25MG ***. + LETHARGYDX ENCOUNTER SCREENING
2YOM C/O DRUG OVERDOSE. FAMILY REPORTS PATIENT POSSIBLY TOOK 2 *** TABLETS. MOTHER FOUND CHILD WITH *** TABLETS IN HIS MOUTH. POISON CONTROL CONTACTED AND RECOMMENDED ACTIVATED CHARCOAL AND OBSERVATION. DX: ACCIDENTAL OVERDOSE
4YOM ACCIDENTALLY INGESTED WOMEWHERE BETWEEN 52 TO 122MG OF ***, MOTHER FOUND OPEN PACKS AROUND HIM. PT ACTING NORMALLY. DX: MEDICATION OVERDOSE, ACCIDENTAL OVERDOSE OF ***
19MOF CHILD POSSIBLE INGESTION OF AN UNKNOWN AMOUNT OF DIPHENHYDRAMINE 50MG GEL CAPSULES DX: ACCIDENTAL DRUG INGESTION
2YOM REPORTS WITH POSSIBLE INGESTION. PATIENT'S MOTHER STATES SHE WAS HAVING A DISAGREEMENT WITH THE BABY'S FATHER (POLYSUBSTANCE ABUSER) WHO WAS ABUSING PROMETHAZINE. FATHER HAD MIXED THE PROMETHAZINE WITH A GREEN JUICE AND MOTHER THINKS PATINET MAY HAVE SWALLOWED IT. DX POSSIBLE INGESTION.
2 YOF C/O POSSIBLE DRUG OVERDOSE. PER PARENTS FOUND WITH OPEN BOTTLE OF *** AND PILLS SCATTERED ACROSS HER. PARENTS UNSURE IF PATIENT HAD INGESTED ANY. PATIENT WAS THEN PUT TO BED. PATIENT WOKE UP IN THE MIDDLE THE NIGHT AND APPEARED TO BE CONFUSED ACTING BIZARRE AND NOT TALKING. DX ACCIDENTAL DRUG INGESTION
2YOM TO ER W/ MOM FOR SUSPECTED INGESTION OF *** BRAND MAXIMUM STRENGTH SINUS CONGESTION PHENYLEPHRINE HCL 10MG BLISTER PACK IN HAND , MOM SAYS 4 TABS MISSING & SAYS SHE MAY HAVE TAKEN DURING PREVIOUS ILLNESS, DOES NOT REMEMBER , SHE SAYS THERE WAS NO EVIDENCE OF PILLS IN PTS MOUTH, PT VOMITED 1X DX OBSERVATION FOR SUSPECTED TOXIC EFFECT FROM INGESTED SUBSTANCE
18 MOM PRESENTS WITH POSSIBLE ACCIDENTAL INGESTION OF DOXYLAMINE 25 MG TABLETS. MOM WOKE AND THE BOTTLE WAS SPILLED ON THE FLOOR. DX: NO DX, LEFT WITHOUT BEING SEEN.
23MOM INGESTED AN ENTIRE BOTTLE OF CHILDREN'S *** ALLERGY MEDICATION LIQUID DX: ANTICHOLINERGIC DRUG OVERDOSE
15MOM PRESENTS AFTER ACCIDENTAL INGESTION OF *** AND MELATONIN. DX: DRUG INGESTION ACCIDENTAL
3YOF PRESENTS AFTER INGESTING 20 TABLETS OF 4MG *** OUT OF A BLISTER PACK AT HOME. MOM REPORTS SHE CLIMBED UP ON A SHELF AND GOT THE MEDICATION. DX; ACCIDENTAL OVERDOSE
4YOM INGESTED 4 OZ OF *** THIS MORNING. MOTHER CALLED POISON CONTROL WHO REFERRED HIM TO THE ED. DX: ACCIDENTAL DRUG INGESTION
Consumer Incident Reports
Reports filed by consumers on SaferProducts.gov.
I am reporting a faulty child safety cap on a bottle of Kirkland brand Children's Allertec liquid medicine (generic for [REDACTED]). My 2.5 year old daughter found a bottle of this medicine, opened it by herself, and ingested a large dose on 11/15/2016. She experienced negative effects from the medicine, and had to be taken to the emergency room. I tested the cap after finding her with the bottle, and found that though the cap said that it was a child safety cap, it did not offer any resistance to being simply unscrewed easily by a child. It behaved like a normal twist-off cap, not a safety cap.
Product Recalls
Search for active and past recalls related to antihistamines on the CPSC website.
Compare beyond Transportation & Substances
Nationwide peers by danger score, ER volume & hospitalization
Three PlainSafety-derived comparison paths for Antihistamines: cross-group products nearest on danger score (36/100), estimated annual ER visits (4,808/yr), and hospitalization share (7.1%). Same-group neighbours stay in Related Products above.
Similar danger score
Nearest cross-group products by PlainSafety danger score (100-point scale).
Similar ER visit volume
Nearest cross-group products by NEISS estimated annual ER visits.
- Water Slides, Public (stationary Amusement Rides) Sports Protective Equipment & Gear 4,800/yr
- Bathtub Or Shower Enclosures, Not Specified Floors, Walls & Ceilings 4,795/yr
- Mountain Climbing (activity, Apparel Or Equipment) Sports & Recreation Equipment 4,791/yr
- Tricycles Toys & Children's Recreation 4,779/yr
Similar hospitalization rate
Nearest cross-group products by % of NEISS ER visits resulting in hospital admission.
Related Products in Transportation & Substances
Read with this product
About this data
CPSC National Electronic Injury Surveillance System (NEISS) 2005–2024 and SaferProducts.gov consumer incident reports form the basis of this page. Injury estimates are based on a nationally representative probability sample of U.S. hospital emergency departments.
According to PlainSafety's CPSC NEISS corpus ranking, Antihistamines ranks #370 of 838 scored CPSC product categories by PlainSafety danger score and #294 of 838 by 20-year estimated ER injury volume.
Frequently Asked Questions
Where does antihistamines rank on danger score versus ER volume?
Among 838 scored CPSC product categories, antihistamines ranks #370 by PlainSafety danger score (36/100) and #294 by 20-year estimated ER injury volume (4,808/yr). The two rankings come from the same NEISS extract and are not the same order.
What are the most common injuries from antihistamines?
The most common injury is poisoning to the all parts body, accounting for approximately 96,106 injuries over 20 years.
Are injuries from antihistamines increasing or decreasing?
Down 23% over 5 years.
Who is most at risk for antihistamines injuries?
The 0-4 age group accounts for the most injuries, with approximately 96,160 cases recorded over 20 years. Males are more frequently injured in this age group.
What happens when someone is injured by antihistamines?
Of all ER visits involving antihistamines, approximately 7.1% result in hospital admission. The majority of patients (92.9%) are treated and released from the emergency department.
How can I report a safety problem with antihistamines?
You can file a consumer incident report at SaferProducts.gov, the official CPSC reporting portal. Reports help the CPSC identify emerging hazards and trigger investigations or recalls. You can also call the CPSC hotline at 1-800-638-2772.
PlainSafety is rendered directly from U.S. Consumer Product Safety Commission recall and incident records, no number is typed in by an editor. Product recall timelines and hazard labels are drawn from CPSC recall records for this product. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.